Turnover—
EBIT margin—
Net result€39k
Working capital€40k
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Epitech Research is 2.4% (average). The 2023 annual accounts show equity of €42k and a net result of €39k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 1 annual account.
Financials
FY 2023
€42k
equity
Turnover—
Net result€39kHealth93/100 · Excellent
See full annual accounts
People & board
No director data processed yet.
To directors Publications
No State Gazette publications linked.
To publications Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsMore than 3 years active
Founded in 2023 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone2.4%
Average
0%0,5%1,5%4%10%≥25%
Young company
+Higher-failure-rate region
+Lower-failure-rate sector
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110Ontwerpen en programmeren van computerprogramma's62010Ontwerpen van computerprogramma’s62100
Primary activity highlighted.
Names & trade names
| Legal nameFR | Epitech Research |
Registered office
Waterleliënlaan 32
1160 Oudergem, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.